CVS Health Corporation Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $1.63 | $1.76 | $1.70 |
Q2 2024 | 5 | $1.73 | $1.74 | $1.74 |
Q3 2024 | 12 | $1.51 | $1.52 | $1.52 |
Q4 2024 | 5 | $1.65 | $1.65 | $1.65 |
Q1 2025 | 6 | $1.46 | $1.46 | $1.46 |
Q2 2025 | 6 | $1.92 | $1.92 | $1.92 |
Q3 2025 | 6 | $1.92 | $1.92 | $1.92 |
Q4 2025 | 6 | $1.78 | $1.78 | $1.78 |
Q1 2026 | 8 | $1.73 | $1.73 | $1.73 |
Q2 2026 | 8 | $2.12 | $2.12 | $2.12 |
Q3 2026 | 8 | $2.11 | $2.11 | $2.11 |
Q4 2026 | 8 | $2.01 | $2.01 | $2.01 |
CVS Health Corporation Earnings Date And Information
CVS Health Corporation last posted its earnings results on Wednesday, August 7th, 2024. The company reported $1.83 earnings per share for the quarter, topping analysts' consensus estimates of $1.73 by $0.1. The company had revenue of 91.32 B for the quarter and had revenue of 356.62 B for the year. CVS Health Corporation has generated $6 earnings per share over the last year ($6.47 diluted earnings per share) and currently has a price-to-earnings ratio of 9.75. CVS Health Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
CVS Health Corporation Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/07/2024 | Q2 2024 | $1.73 | $1.41 | -0.32 | $91.41 B | $91.32 B |
05/01/2024 | Q1 2024 | $1.70 | $0.88 | -0.82 | $87.98 B | |
02/07/2024 | Q4 2023 | $2.01 | $1.59 | -0.42 | $93.55 B | |
11/01/2023 | Q3 2023 | $2.13 | $1.76 | -0.37 | $88.30 B | $89.49 B |
08/02/2023 | Q2 2023 | $2.12 | $1.48 | -0.64 | $86.41 B | $88.65 B |
05/03/2023 | Q1 2023 | $2.07 | $1.66 | -0.41 | $84.94 B | |
02/08/2023 | Q4 2022 | $1.92 | $1.78 | -0.14 | $83.52 B | |
11/02/2022 | Q3 2022 | $1.99 | -$2.59 | -4.58 | $76.74 B | $80.96 B |
08/03/2022 | Q2 2022 | $2.17 | $2.31 | 0.14 | $76.41 B | $80.49 B |
05/04/2022 | Q1 2022 | $2.15 | $1.79 | -0.36 | $76.66 B | |
02/09/2022 | Q4 2021 | $1.94 | $0.99 | -0.95 | $76.60 B | |
11/03/2021 | Q3 2021 | $1.79 | $1.21 | -0.58 | $70.52 B | $73.79 B |
08/04/2021 | Q2 2021 | $2.06 | $2.11 | 0.05 | $70.24 B | $72.62 B |
05/04/2021 | Q1 2021 | $1.72 | $1.69 | -0.03 | $69.10 B | |
02/16/2021 | Q4 2020 | $1.24 | $0.74 | -0.5 | $69.55 B | |
11/06/2020 | Q3 2020 | $1.34 | $0.93 | -0.41 | $66.62 B | $67.06 B |
08/05/2020 | Q2 2020 | $1.93 | $2.27 | 0.34 | $64.00 B | $65.34 B |
05/06/2020 | Q1 2020 | $1.63 | $1.54 | -0.09 | $66.76 B | |
02/18/2020 | Q4 2019 | $1.34 | $66.89 B | |||
11/06/2019 | Q3 2019 | $1.77 | $1.17 | -0.6 | $63.02 B | $64.81 B |
CVS Health Corporation Earnings: Frequently Asked Questions
-
When is CVS Health Corporation's earnings date?
CVS Health Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
Did CVS Health Corporation beat their earnings estimates last quarter?
In the previous quarter, CVS Health Corporation (:CVS) reported $1.83 earnings per share (EPS) to beat the analysts' consensus estimate of $1.73 by $0.1.
-
How can I listen to CVS Health Corporation's earnings conference call?
The conference call for CVS Health Corporation's latest earnings report can be listened to online.
-
How can I read CVS Health Corporation's conference call transcript?
The conference call transcript for CVS Health Corporation's latest earnings report can be read online.
-
How much revenue does CVS Health Corporation generate each year?
CVS Health Corporation (:CVS) has a recorded annual revenue of $356.62 B.
-
How much profit does CVS Health Corporation generate each year?
CVS Health Corporation (:CVS) has a recorded net income of $356.62 B. CVS Health Corporation has generated $6.49 earnings per share over the last four quarters.
-
What is CVS Health Corporation's price-to-earnings ratio?
CVS Health Corporation (:CVS) has a price-to-earnings ratio of 9.75 and price/earnings-to-growth ratio is -7.95.